Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ambrx Biopharma, Inc. (AMAM) since 2023 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ambrx Biopharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1990550.
Total stock buying since 2023: $9,139,411.
Total stock sales since 2023: $616,596.
Total stock option exercises since 2023: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 1,307,311 | $9,139,411 | 62,790 | $616,596 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-10 | 1,307,311 | $9,139,411 | 62,790 | $616,596 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-10-27 | Nelson Sonja (Chief Financial Officer) | Sale | 12,778 | 9.82 | 125,479 |
| 2023-10-27 | O'connor Daniel J. (President and CEO) | Sale | 50,012 | 9.82 | 491,117 |
| 2023-10-23 | Cormorant Private Healthcare Fund Iii Lp | Buy | 1,307,311 | 6.99 | 9,139,411 |
Insider trading activities including stock purchases, stock sales, and option exercises of AMAM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ambrx Biopharma, Inc. (symbol AMAM, CIK number 1990550) see the Securities and Exchange Commission (SEC) website.